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Figure 1: Root mean square deviation of wild-type (A), R1H (B) and R1G (C) mutant VSD of Cav1.1 






Figure 2: Root mean square deviation of wild-type, R1S and R2S mutant VSD of Cav1.1 domain III in 











Figure 3: 2d-rmsd of all Cα atoms in wild-type (A) and R2H mutant (B) VSD of Cav1.1 domain IV in 
the resting state β. The wild-type protein is more stable than the mutant as the simulation converges 
earlier. Whereas the MD simulation of the mutant requires a longer simulation time to converge. 
 
Figure 4: 2d-rmsd of transmembrane Cα atoms in wild-type (A) and R3H mutant (B) VSD of Cav1.3 






Figure 5: Averaged occupancy values over 100 ns and whole transmembrane segments in the resting 
state α of the Cav1.1 VSD of domain II R1G (A) and III R1S (B).  
A: Compared to the wild-type, segment S3 loses its helical secondary structure and changes toward a 
beta turn. 
B: All segments show a prevalent alpha helical secondary structure, but S4 presents also 3-10 helix 






Figure 6. (A) WT II domain VSD in the resting state α modelled without intra- and extra-cellular 
linkers. The only difference to the model including loops (Fig. 1) is that R1 forms ionic interactions 
with E4 because E452 from S1-S2 loop was removed from the structure. (B) The presence or absence of 





Figure 7: R1S and R2S mutant VSDs of domain III in the resting state β (A) and α (B). The protein is 
represented as cartoons, colored as rainbow according to the residue number: segment S1, lipids and 
hydrogen atoms are not shown for clearness. Gating charges are shown as lines, whereas mutated 
residues are highlighted as sticks. H-bonds are marked with yellow dots. Average water density during 
the simulation is shown as transparent cyan surface. The average number of water molecules in the 
VSD is calculated for each frame. 
A: R1S does not result in a water wire in the resting state β because R0 and R2 seal the center of the 
VSD. R1S forms H-bond interactions with the backbone of S4 that are conserved in helical secondary 
structure elements. The ionic interaction between R2 and E2 causes a conformational change of helix 
S4 that forms a kink at R2 level. 
B: in the resting state α, R2S does not cause a water wire as water molecules can enter only from the 






Figure 8: Mutation of R1 charge to His in CaV1.3 channel does not alter the voltage dependence of 
the steady-state inactivation. A. Voltage dependence of steady state inactivation (squares) was 
measured by applying a control test pulse (20 ms to the voltage of maximal inward current, Vmax) 
followed by 5-s conditioning steps to various potentials and a subsequent 20-ms test pulse to Vmax (30-s 
recovery between sweeps). Inactivation was calculated as the ratio between the current amplitudes of 
the test versus control pulse. Whereas the voltage-dependence of activation (circles) of CaV1.3-R990H 
was significantly shifted by ~3 mV towards more depolarizing potentials compared to WT CaV1.3 
channel (same data as in Figure 5B), the voltage dependence of steady-state inactivation (WT V0.5 =-
30.8 ± 1.14, n=16; R990H V0.5 = -32.5 ± 1.12, n = 18) or the slope of the voltage dependence of 








Figure 9. The amplitude of CaV1.3-R990H guanidinium current (IG) negatively correlates with the 
number of channels functionally incorporated in the membrane (QON). The linear regression fit of the 
dependence between IG measured at -100 mV and the QON measured at the reversal potential shows a 
statistically significant correlation for the CaV1.3-R990H (p <0.05) but not for WT CaV1.3. Since our 
experimental data shows that the mock transfected cells (no α1 subunit) (N=12) also conduct a 
guanidinium current we included these values in both WT (N=12) and R990H (N=15) fit functions. 










Figure 10. CaV1.1 III VSD bearing the V876E mutation modelled in the resting state α (A) and β 
(B). The modelling predicts the formation of a water wire independent of the gating state. In the resting 
state α, V876E forms ionic interactions with R2, which moves upwards compared to WT and allows E2 
to interact with water molecules. In addition, V876E drives water to the hydrophobic center, which 
becomes polar due to the introduction of a charged amino acid. In the resting state β, the ionic 
interactions of R2 with V876E are replaced by R1. 
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Supplemental Information - Tables 
Table 1: Up-to-date list of mutations in voltage-gated calcium channels that develop or might develop 
omega currents. Highlighted cells indicate experimentally measured omega-currents. For further 
mutations at voltage sensors of ion channels we refer to the review of Jurkat-Rott et al. (1). 
Isoform Domain Mutation N. Disease References Functional Effect 
Cav1.1 
I R174W R4 MHS (2) α-pore gain of function 
II 
R528G/H R1 HPP (3-9) α-pore gain or loss of function and ω-current 
R528C R1 HPP (10) n.c. 
III 
 
V876E  HPP  n.c. 
R897S R1 HPP (11) n.c. 
R900G/S R2 HPP (12, 13) n.c. 
IV R1239G/H R2 HPP (7-9, 14, 15) α-pore gain of function and leak current  
Cav1.3 
II R619W R1 APAs (16) n.c. 
III R990H R3 APAs (17) α-pore not affected but ω-current  
Cav2.1 
I 
R192Q R0 FHM (18-21) α-pore gain of function 
R195K R1 FHM (22) n.c. 
II R583Q R1 FHM (22-24) α-pore gain of function 
III 
R1347Q R1 FHM (25, 26) n.c. 
R1350Q R2 EA2 (27, 28) α-pore gain of function 
IV 
R1661H R1 FHM (29) n.c. 
R1664Q R2 FHM (30) n.c. 
R1667W R3 FHM (22) n.c. 
 
APAs: adrenal aldosterone-producing adenomas 
EA2: episodic ataxia type 2 
FHM: familial hemiplegic migraine 
HPP: hypokalemic periodic paralysis 
MHS: malignant hyperthermia susceptibility  
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Table 2: Sequence alignment of Cav1.1, Cav1.3 and Cav2.1 voltage sensors. Green highlighted 
residues represent the gating charges R1 to R4; yellow highlighted residues indicate other positively 






Table 3: Gating charges and counter charges in voltage sensors of Cav1.1 domains II, III and IV 




VSD II VSD III VSD IV VSD III 
F F475 F843 F1161 F930 
R0 S525, R469 K894 R1229 K981 
R1 R528 R897 R1236 R984 
E1/D1 E452 D836 - D923 
R2 R531 R900 R1239 R987 
E2 E478 E846 E1164 E933 
R3 R534 R903 R1242 R990 
D3 D500 D872 D1186 D959 
E4/D4 E510 - D1196 - 
 






II III IV III 
State α State α State β State β State β 
R0 E4 D1 D1 D4 - 
R1 E452 D1 E2 D4 D1 
R2 E2 E2, D3 D3 E2, D3 D3 












Table 5: Averaged helical secondary structure occupancy over 100 ns of whole transmembrane 
segments for WT and mutant VSDs in distinct states. 
 





98% 99% 56% 67% 
R1H 98% 99% 58% 77% 
R1G 100% 99% 29% 93% 
Domain III 
WT 
Resting α 89% 92% 85% 76% 
Resting β 96% 85% 94% 93% 
R1S 
Resting α 79% 94% 95% 59% 
Resting β 99% 98% 89% 83% 
R2S 
Resting α 92% 95% 99% 89% 




88% 98% 95% 67% 
R2H 99% 97% 97% 85% 
Cav1.3 Domain III 
WT 
Resting β 
83% 91% 82% 75% 





Table 6: H-bond counts for WT and R2S mutant of Cav1.1 domain III in distinct states. Gating 
charges are positively charged amino acids in the transmembrane segment S4. Counter charges are 
negatively charged residues in the surrounding segments in the voltage sensor. 
In the WT VSD, R2 forms H-bonds with counter charges (E2 and D3), polar amino acids and water 
molecules. In the mutant, R2S loses the interactions with counter charges in the resting state α whereas 
in the resting state β it can still form H-bonds with a negatively charged residue in the helix S3 (D3). 
 
Resting state α Resting state β 
WT R2S WT R2S 
Gating charges 0 72% 0 1% 
Counter charges 100% 0 97% 85% 
Polar residues 0 1% 67% 0 
Water 93% 7% 23% 0 
 
 
Table 7: H-bond counts for WT and R3H mutant of Cav1.3 domain III in distinct states.  
In the WT voltage sensor, R3 forms H-bonds with counter charges and water molecules. In the mutant, 
R3H loses the interactions with counter charges, but forms H-bonds with polar residues in the active 
state and water molecules in the resting state β. 
 
 
Active state Resting state β 
WT R3H WT R3H 
Gating charges 0 0 0 17% 
Counter charges 33% 0 80% 1% 
Polar residues 0 84% 0 8% 
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